[1]
“Molecular Docking Studies of Berberine Derivative as Novel Multitarget PCSK9 and HMGCR Inhibitors”, Sci. Ess. J, vol. 37, no. 1, pp. 124–142, Jun. 2021, Accessed: Oct. 23, 2026. [Online]. Available: https://ejournals.swu.ac.th/sej/article/view/13502